Agenus UK Ltd

Agenus uses the power of the immune system to develop innovative product candidates against cancer. Its technologies and candidates have the potential to treat cancer as well as other immune-mediated diseases. The company has assembled a broad portfolio of antibodies including checkpoint inhibitors and other checkpoint modulators, neo-antigen vaccines and adjuvants. Agenus’ strategy combines its intellectual and technical assets with its broad pipeline with the aim of bringing curative treatments to cancer patients.

Address

Agenus UK Ltd
315, Cambridge Science Park
Milton Road, Cambridge
Cambridgeshire, United Kingdom
CB4 OWG
Web: http://www.agenusbio.com